Clinic
Victoria of Texas LP
Victoria of Texas LP was paid $7.74M by Medicaid between Sep 2020 and Dec 2024, across 78 billing codes. Its largest line is 99284, emergency room visit (serious) — 48% of everything it billed.
33Billing provider infoVICTORIA OF TEXAS LP
VICTORIA, TX 77901
VICTORIA, TX 77901
33aNPI1851343909assigned 05/17/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$7.74M
24GClaims115,979
24DCodes billed78
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#60 of 320
Median peer was paid$205K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,043 | $145K | |
| 2021 | 37,489 | $2.36M | |
| 2022 | 37,572 | $2.28M | |
| 2023 | 27,277 | $2.09M | |
| 2024incomplete | 11,598 | $858K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 48% | 8,711 | 8,319 | $3.71M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 21,424 | 20,640 | $1.45M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 8.7% | 1,518 | 1,482 | $677K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.2% | 6,975 | 6,772 | $482K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 4,761 | 4,634 | $324K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 2,711 | 2,508 | $113K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 716 | 550 | $86K |
| 87430 | 1.0% | 3,698 | 3,588 | $81K | |
| 87400 | <1% | 3,220 | 1,765 | $67K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,592 | 6,763 | $60K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 335 | 318 | $59K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,350 | 3,171 | $59K |
66 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,519 | $57K |
| 87486 | <1% | 1,519 | $57K | |
| 87581 | <1% | 1,519 | $57K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 940 | $55K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,613 | $47K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,038 | $39K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 153 | $38K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,048 | $31K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 987 | $31K |
| G0378 | Hospital observation service, per hour | <1% | 27 | $27K |
| 81001 | <1% | 9,084 | $26K | |
| 81025 | <1% | 2,326 | $19K | |
| 87081 | <1% | 1,959 | $17K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 690 | $11K |
| CP007 | <1% | 150 | $11K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 192 | $7K |
| 76801 | <1% | 60 | $5K | |
| 83690 | <1% | 1,024 | $5K | |
| 87088 | <1% | 956 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 676 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,085 | $3K |
| 84484 | <1% | 972 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 55 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 166 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 435 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 48 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 182 | $2K |
| 87420 | <1% | 92 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 660 | $2K |
| 82553 | <1% | 540 | $2K | |
| 93976 | <1% | 14 | $1K | |
| 80305 | <1% | 79 | $825.10 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 172 | $551.74 |
| 82550 | <1% | 407 | $542.44 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 375 | $369.96 |
| 84702 | <1% | 30 | $343.69 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,628 | $323.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 77 | $298.44 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 243 | $296.11 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 25 | $271.61 |
| 85027 | <1% | 193 | $239.19 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 226 | $234.80 |
| 86901 | <1% | 178 | $203.31 | |
| 86900 | <1% | 179 | $203.31 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 80 | $198.73 |
| 86850 | <1% | 30 | $177.95 | |
| 85730 | <1% | 476 | $159.48 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 67 | $155.92 |
| 85610 | <1% | 561 | $130.91 | |
| 87186 | <1% | 123 | $101.78 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 180 | $100.25 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 49 | $83.19 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,947 | $65.75 |
| 87077 | <1% | 44 | $61.11 | |
| 82962 | <1% | 1,059 | $57.35 | |
| 0240U | <1% | 218 | $53.92 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 275 | $49.82 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 13 | $35.76 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 331 | $26.00 |
| 85007 | <1% | 24 | $19.14 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 127 | $6.00 |
| 83735 | <1% | 15 | $5.63 | |
| 36416 | <1% | 704 | $3.85 | |
| J2704 | Injection, propofol, 10 mg | 0% | 53 | $0.00 |
| 83880 | 0% | 15 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.